↓ Skip to main content
What is this page? Embed badge

Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2)

Overview of attention for article published in BMC Medicine, August 2022
Altmetric Badge

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
10 Mendeley
Summary Twitter Dimensions citations
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2)
Published in
BMC Medicine, August 2022
DOI 10.1186/s12916-022-02470-6
Pubmed ID
36031613
Authors

Guangjian Yang, Haiyan Xu, Yaning Yang, Shuyang Zhang, Fei Xu, Xuezhi Hao, Junling Li, Puyuan Xing, Xingsheng Hu, Yutao Liu, Lin Wang, Lin, Zhijie Wang, Jianchun Duan, Jie Wang, Yan Wang

View on publisher site

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 30%
Student > Master 2 20%
Student > Ph. D. Student 1 10%
Student > Postgraduate 1 10%
Student > Bachelor 1 10%
Other 0 0%
Unknown 2 20%
Readers by discipline Count As %
Unspecified 3 30%
Medicine and Dentistry 3 30%
Biochemistry, Genetics and Molecular Biology 1 10%
Environmental Science 1 10%
Unknown 2 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 September 2022.
All research outputs
#18,734,471
of 23,221,875 outputs
Outputs from BMC Medicine
#3,260
of 3,496 outputs
Outputs of similar age
#299,650
of 432,757 outputs
Outputs of similar age from BMC Medicine
#111
of 121 outputs
Altmetric has tracked 23,221,875 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,496 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 43.7. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,757 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one is in the 2nd percentile – i.e., 2% of its contemporaries scored the same or lower than it.

This page is provided by Altmetric.